Ho-Sup Lee

发表

Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload

Il-Hwan Kim, S. Sohn, Gyeong-Won Lee, 2015, Transfusion.

Chemotherapy adherence is a favorable prognostic factor for elderly patients with multiple myeloma who are treated with a frontline bortezomib-containing regimen

J. Lee, Y. Lee, Sung hyun Kim, 2018, Yeungnam University journal of medicine.

Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD

H. Yhim, Hyeoung-Joon Kim, S. Sohn, 2022, Cell transplantation.

Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement

Seong-Jang Kim, Gyeong-Won Lee, Ho-Jin Shin, 2011, Annals of Hematology.

Waldeyer’s ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL)

Jinny Park, Dae-Ho Lee, Byeong-Bae Park, 2012, International Journal of Hematology.

Stage IV marginal zone B‐cell lymphoma – prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study

Jinny Park, Dae-Ho Lee, I. Hwang, 2010, Cancer science.

Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study

Jinny Park, Dae-Ho Lee, I. Hwang, 2010, International journal of hematology.

Prognostic value of Waldeyer’s ring involvement of diffuse large B-cell lymphoma treated with R-CHOP

Gyeong-Won Lee, Moo-Kon Song, Ho-Jin Shin, 2013, International Journal of Hematology.

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.

Jinny Park, Young-Uk Cho, Kihyun Kim, 2015, Blood.

The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea

J. Lee, Kihyun Kim, S. Kim, 2016, Annals of Hematology.

Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma

Kihyun Kim, Je-Jung Lee, W. Lee, 2014, European Journal of Haematology.

A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2017, Oncotarget.

Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma

Ho-Jin Shin, Ho-Sup Lee, Gyeong-Won Lee, 2012, Cancer science.

Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study

K. Yoo, Byeong-Bae Park, S. Kim, 2021, Cancer research and treatment.

Clinical value of metabolic tumor volume by PET/CT in extranodal natural killer/T cell lymphoma.

Seong-Jang Kim, Gyeong-Won Lee, Jae-Sook Ahn, 2013, Leukemia research.

Chronic Hepatitis B Viral Activity Enough to Take Antiviral Drug Could Predict the Survival Rate in Malignant Lymphoma

J. Jo, Sangjin Lee, Jee-Yeong Jeong, 2022, Viruses.

Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT

C. Hong, S. Jeong, Kihyun Kim, 2021, Blood Cancer Journal.

Clinical Value of Absolute Lymphocyte Counts before Bortezomib-Dexamethasone Therapy in Relapsed Multiple Myeloma Patients

Y. Seol, Gyeong-Won Lee, Y. Joo, 2010, Acta Haematologica.

Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairment

Sung-Soo Yoon, Y. Do, Je-Jung Lee, 2012, Annals of Hematology.

Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study

H. Eom, Y. Lee, S. Sohn, 2023, The Korean journal of internal medicine.

Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation

K. Yoo, S. Kim, H. Eom, 2023, Blood cancer journal.

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation

S. Kim, H. Kang, H. Eom, 2023, Frontiers in oncology.

A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study

H. Eom, J. Jo, Deok-Hwan Yang, 2023, Blood research.

Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement

Seong-Jang Kim, Gyeong-Won Lee, Ho-Jin Shin, 2011, Annals of Hematology.

Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts

K. Yoo, Byeong-Bae Park, S. Kim, 2022, Cancer research and treatment.

Stage IV marginal zone B‐cell lymphoma – prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study

Jinny Park, Dae-Ho Lee, I. Hwang, 2010, Cancer science.

Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial

Deok-Hwan Yang, J. Byun, J. Kwak, 2024, Nature communications.

Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era

H. Yhim, D. Baek, Ho-Sup Lee, 2024, Frontiers in oncology.